Cargando…
The Human Mixed Lineage Leukemia 5 (MLL5), a Sequentially and Structurally Divergent SET Domain-Containing Protein with No Intrinsic Catalytic Activity
Mixed Lineage Leukemia 5 (MLL5) plays a key role in hematopoiesis, spermatogenesis and cell cycle progression. Chromatin binding is ensured by its plant homeodomain (PHD) through a direct interaction with the N-terminus of histone H3 (H3). In addition, MLL5 contains a Su(var)3-9, Enhancer of zeste,...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094779/ https://www.ncbi.nlm.nih.gov/pubmed/27812132 http://dx.doi.org/10.1371/journal.pone.0165139 |
_version_ | 1782465172899627008 |
---|---|
author | Mas-y-Mas, Sarah Barbon, Marta Teyssier, Catherine Déméné, Hélène Carvalho, João E. Bird, Louise E. Lebedev, Andrey Fattori, Juliana Schubert, Michael Dumas, Christian Bourguet, William le Maire, Albane |
author_facet | Mas-y-Mas, Sarah Barbon, Marta Teyssier, Catherine Déméné, Hélène Carvalho, João E. Bird, Louise E. Lebedev, Andrey Fattori, Juliana Schubert, Michael Dumas, Christian Bourguet, William le Maire, Albane |
author_sort | Mas-y-Mas, Sarah |
collection | PubMed |
description | Mixed Lineage Leukemia 5 (MLL5) plays a key role in hematopoiesis, spermatogenesis and cell cycle progression. Chromatin binding is ensured by its plant homeodomain (PHD) through a direct interaction with the N-terminus of histone H3 (H3). In addition, MLL5 contains a Su(var)3-9, Enhancer of zeste, Trithorax (SET) domain, a protein module that usually displays histone lysine methyltransferase activity. We report here the crystal structure of the unliganded SET domain of human MLL5 at 2.1 Å resolution. Although it shows most of the canonical features of other SET domains, both the lack of key residues and the presence in the SET-I subdomain of an unusually large loop preclude the interaction of MLL5 SET with its cofactor and substrate. Accordingly, we show that MLL5 is devoid of any in vitro methyltransferase activity on full-length histones and histone H3 peptides. Hence, the three dimensional structure of MLL5 SET domain unveils the structural basis for its lack of methyltransferase activity and suggests a new regulatory mechanism. |
format | Online Article Text |
id | pubmed-5094779 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-50947792016-11-18 The Human Mixed Lineage Leukemia 5 (MLL5), a Sequentially and Structurally Divergent SET Domain-Containing Protein with No Intrinsic Catalytic Activity Mas-y-Mas, Sarah Barbon, Marta Teyssier, Catherine Déméné, Hélène Carvalho, João E. Bird, Louise E. Lebedev, Andrey Fattori, Juliana Schubert, Michael Dumas, Christian Bourguet, William le Maire, Albane PLoS One Research Article Mixed Lineage Leukemia 5 (MLL5) plays a key role in hematopoiesis, spermatogenesis and cell cycle progression. Chromatin binding is ensured by its plant homeodomain (PHD) through a direct interaction with the N-terminus of histone H3 (H3). In addition, MLL5 contains a Su(var)3-9, Enhancer of zeste, Trithorax (SET) domain, a protein module that usually displays histone lysine methyltransferase activity. We report here the crystal structure of the unliganded SET domain of human MLL5 at 2.1 Å resolution. Although it shows most of the canonical features of other SET domains, both the lack of key residues and the presence in the SET-I subdomain of an unusually large loop preclude the interaction of MLL5 SET with its cofactor and substrate. Accordingly, we show that MLL5 is devoid of any in vitro methyltransferase activity on full-length histones and histone H3 peptides. Hence, the three dimensional structure of MLL5 SET domain unveils the structural basis for its lack of methyltransferase activity and suggests a new regulatory mechanism. Public Library of Science 2016-11-03 /pmc/articles/PMC5094779/ /pubmed/27812132 http://dx.doi.org/10.1371/journal.pone.0165139 Text en © 2016 Mas-y-Mas et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Mas-y-Mas, Sarah Barbon, Marta Teyssier, Catherine Déméné, Hélène Carvalho, João E. Bird, Louise E. Lebedev, Andrey Fattori, Juliana Schubert, Michael Dumas, Christian Bourguet, William le Maire, Albane The Human Mixed Lineage Leukemia 5 (MLL5), a Sequentially and Structurally Divergent SET Domain-Containing Protein with No Intrinsic Catalytic Activity |
title | The Human Mixed Lineage Leukemia 5 (MLL5), a Sequentially and Structurally Divergent SET Domain-Containing Protein with No Intrinsic Catalytic Activity |
title_full | The Human Mixed Lineage Leukemia 5 (MLL5), a Sequentially and Structurally Divergent SET Domain-Containing Protein with No Intrinsic Catalytic Activity |
title_fullStr | The Human Mixed Lineage Leukemia 5 (MLL5), a Sequentially and Structurally Divergent SET Domain-Containing Protein with No Intrinsic Catalytic Activity |
title_full_unstemmed | The Human Mixed Lineage Leukemia 5 (MLL5), a Sequentially and Structurally Divergent SET Domain-Containing Protein with No Intrinsic Catalytic Activity |
title_short | The Human Mixed Lineage Leukemia 5 (MLL5), a Sequentially and Structurally Divergent SET Domain-Containing Protein with No Intrinsic Catalytic Activity |
title_sort | human mixed lineage leukemia 5 (mll5), a sequentially and structurally divergent set domain-containing protein with no intrinsic catalytic activity |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094779/ https://www.ncbi.nlm.nih.gov/pubmed/27812132 http://dx.doi.org/10.1371/journal.pone.0165139 |
work_keys_str_mv | AT masymassarah thehumanmixedlineageleukemia5mll5asequentiallyandstructurallydivergentsetdomaincontainingproteinwithnointrinsiccatalyticactivity AT barbonmarta thehumanmixedlineageleukemia5mll5asequentiallyandstructurallydivergentsetdomaincontainingproteinwithnointrinsiccatalyticactivity AT teyssiercatherine thehumanmixedlineageleukemia5mll5asequentiallyandstructurallydivergentsetdomaincontainingproteinwithnointrinsiccatalyticactivity AT demenehelene thehumanmixedlineageleukemia5mll5asequentiallyandstructurallydivergentsetdomaincontainingproteinwithnointrinsiccatalyticactivity AT carvalhojoaoe thehumanmixedlineageleukemia5mll5asequentiallyandstructurallydivergentsetdomaincontainingproteinwithnointrinsiccatalyticactivity AT birdlouisee thehumanmixedlineageleukemia5mll5asequentiallyandstructurallydivergentsetdomaincontainingproteinwithnointrinsiccatalyticactivity AT lebedevandrey thehumanmixedlineageleukemia5mll5asequentiallyandstructurallydivergentsetdomaincontainingproteinwithnointrinsiccatalyticactivity AT fattorijuliana thehumanmixedlineageleukemia5mll5asequentiallyandstructurallydivergentsetdomaincontainingproteinwithnointrinsiccatalyticactivity AT schubertmichael thehumanmixedlineageleukemia5mll5asequentiallyandstructurallydivergentsetdomaincontainingproteinwithnointrinsiccatalyticactivity AT dumaschristian thehumanmixedlineageleukemia5mll5asequentiallyandstructurallydivergentsetdomaincontainingproteinwithnointrinsiccatalyticactivity AT bourguetwilliam thehumanmixedlineageleukemia5mll5asequentiallyandstructurallydivergentsetdomaincontainingproteinwithnointrinsiccatalyticactivity AT lemairealbane thehumanmixedlineageleukemia5mll5asequentiallyandstructurallydivergentsetdomaincontainingproteinwithnointrinsiccatalyticactivity AT masymassarah humanmixedlineageleukemia5mll5asequentiallyandstructurallydivergentsetdomaincontainingproteinwithnointrinsiccatalyticactivity AT barbonmarta humanmixedlineageleukemia5mll5asequentiallyandstructurallydivergentsetdomaincontainingproteinwithnointrinsiccatalyticactivity AT teyssiercatherine humanmixedlineageleukemia5mll5asequentiallyandstructurallydivergentsetdomaincontainingproteinwithnointrinsiccatalyticactivity AT demenehelene humanmixedlineageleukemia5mll5asequentiallyandstructurallydivergentsetdomaincontainingproteinwithnointrinsiccatalyticactivity AT carvalhojoaoe humanmixedlineageleukemia5mll5asequentiallyandstructurallydivergentsetdomaincontainingproteinwithnointrinsiccatalyticactivity AT birdlouisee humanmixedlineageleukemia5mll5asequentiallyandstructurallydivergentsetdomaincontainingproteinwithnointrinsiccatalyticactivity AT lebedevandrey humanmixedlineageleukemia5mll5asequentiallyandstructurallydivergentsetdomaincontainingproteinwithnointrinsiccatalyticactivity AT fattorijuliana humanmixedlineageleukemia5mll5asequentiallyandstructurallydivergentsetdomaincontainingproteinwithnointrinsiccatalyticactivity AT schubertmichael humanmixedlineageleukemia5mll5asequentiallyandstructurallydivergentsetdomaincontainingproteinwithnointrinsiccatalyticactivity AT dumaschristian humanmixedlineageleukemia5mll5asequentiallyandstructurallydivergentsetdomaincontainingproteinwithnointrinsiccatalyticactivity AT bourguetwilliam humanmixedlineageleukemia5mll5asequentiallyandstructurallydivergentsetdomaincontainingproteinwithnointrinsiccatalyticactivity AT lemairealbane humanmixedlineageleukemia5mll5asequentiallyandstructurallydivergentsetdomaincontainingproteinwithnointrinsiccatalyticactivity |